Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis

Human Molecular Genetics

Volumn 18, Issue 5, 2009, Pages 956-965

  Pacheco, Chris D ^a   Elrick, Matthew J ^a   Lieberman, Andrew P ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; PROTEIN NPC1; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; MOUSE; NERVE DEGENERATION; NIEMANN PICK DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM;

ANIMALS; AUTOPHAGY; CARRIER PROTEINS; CELLS, CULTURED; FEMALE; FIBROBLASTS; GENE DELETION; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NIEMANN-PICK DISEASE, TYPE C; PHENOTYPE; PROTEINS; TAU PROTEINS;

MUS;

EID: 60549091933     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn423     Document Type: Article

References (67)

1. Higgins, J.J., Patterson, M.C., Dambrosia, J.M., Pikus, A.T., Pentchev, P.G., Sato, S., Brady, R.O. and Barton, N.W. (1992) A clinical staging classification for type C Niemann-Pick disease. Neurology, 42 2286-2290.
2. Carstea, E.D., Morris, J.A., Coleman, K.G., Loftus, S.K., Zhang, D., Cummings, C., Gu, J., Rosenfeld, M.A., Pavan, W.J., Krizman, D.B. et al. (1997) Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis. Science, 277, 228-231.
3. Ioannou, Y.A. (2001) Multidrug permeases and subcellular cholesterol transport. Nat. Rev. Mol. Cell Biol., 2, 657-668.
4. Davies, J.P., Chen, F.W. and Ioannou, Y.A. (2000) Transmembrane molecular pump activity of Niemann-Pick C1 protein. Science, 290, 2295-2298.
5. Garver, W.S., Heidenreich, R.A., Erickson, R.P., Thomas, M.A. and Wilson, J.M. (2000) Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments. J. Lipid Res., 41 673-687.
6. Higgins, M.E., Davies, J.P., Chen, F.W. and Ioannou, Y.A. (1999) Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol. Genet. Metab., 68, 1-13.
7. Neufeld, E.B., Wastney, M., Patel, S., Suresh, S., Cooney, A.M., Dwyer, N.K., Roff, C.F., Ohno, K., Morris, J.A., Carstea, E.D. et al. (1999) The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J. Biol. Chem., 274, 9627-9635.
8. Wojtanik, K.M. and Liscum, L. (2003) The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells. J. Biol. Chem., 278, 14850-14856.
9. Liscum, L., Ruggiero, R.M. and Faust, J.R. (1989) The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts. J. Cell Biol., 108, 1625-1636.
10. Sokol, J., Blanchette-Mackie, J., Kruth, H.S., Dwyer, N.K., Amende, L.M., Butler, J.D., Robinson, E., Patel, S., Brady, R.O., Comly, M.E. et al. (1988) Type C Niemann-Pick disease. Lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol. J. Biol. Chem., 263, 3411-3417.
11. Loftus, S.K., Morris, J.A., Carstea, E.D., Gu, J.Z., Cummings, C., Brown, A., Ellison, J., Ohno, K., Rosenfeld, M.A., Tagle, D.A. et al. (1997) Murine model of Niemann-Pick C disease: Mutation in a cholesterol homeostasis gene. Science, 277, 232-235.
12. Walkley, S.U. (1995) Pyramidal neurons with ectopic dendrites in storage diseases exhibit increased GM2 ganglioside immunoreactivity. Neuroscience, 68, 1027-1035.
13. Xie, C., Burns, D.K., Turley, S.D. and Dietschy, J.M. (2000) Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased. J. Neuropathol. Exp. Neurol., 59, 1106-1117.
14. Zervas, M., Dobrenis, K. and Walkley, S.U. (2001) Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J. Neuropathol. Exp. Neurol., 60, 49-64.
15. Takikita, S., Fukuda, T., Mohri, I., Yagi, T. and Suzuki, K. (2004) Perturbed myelination process of premyelinating oligodendrocyte in Niemann-Pick type C mouse. J. Neuropathol. Exp. Neurol., 63, 660-673.
16. Bu, B., Li, J., Davies, P. and Vincent, I. (2002) Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci., 22, 6515-6525.
17. German, D.C., Quintero, E.M., Liang, C.L., Ng, B., Punia, S., Xie, C. and Dietschy, J.M. (2001) Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease. J. Comp. Neurol., 433, 415-425.
18. Higashi, Y., Murayama, S., Pentchev, P.G. and Suzuki, K. (1993) Cerebellar degeneration in the Niemann-Pick type C mouse. Acta Neuropathol. (Berl.), 85, 175-184.
19. Tanaka, J., Nakamura, H. and Miyawaki, S. (1988) Cerebellar involvement in murine sphingomyelinosis: A new model of Niemann-Pick disease. J. Neuropathol. Exp. Neurol., 47, 291-300.
20. Voikar, V., Rauvala, H. and Ikonen, E. (2002) Cognitive deficit and development of motor impairment in a mouse model of Niemann-Pick type C disease. Behav. Brain Res., 132, 1-10.
21. Auer, I.A., Schmidt, M.L., Lee, V.M., Curry, B., Suzuki, K., Shin, R.W., Pentchev, P.G., Carstea, E.D. and Trojanowski, J.Q. (1995) Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease. Acta Neuropathol. (Berl.), 90 547-551.
22. Love, S., Bridges, L.R. and Case, C.P. (1995) Neurofibrillary tangles in Niemann-Pick disease type C. Brain, 118, 119-129.
23. Ballatore, C., Lee, V.M. and Trojanowski, J.Q. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci., 8, 663-672.
24. Hirokawa, N., Shiomura, Y. and Okabe, S. (1988) Tau proteins: The molecular structure and mode of binding on microtubules. J. Cell Biol., 107, 1449-1459.
25. Lee, G., Neve, R.L. and Kosik, K.S. (1989) The microtubule binding domain of tau protein. Neuron, 2, 1615-1624.
26. Alonso, A.C., Grundke-Iqbal, I. and Iqbal, K. (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med., 2, 783-787.
27. Dixit, R., Ross, J.L., Goldman, Y.E. and Holzbaur, E.L. (2008) Differential regulation of dynein and kinesin motor proteins by tau. Science, 319, 1086-1089.
28. Magnani, E., Fan, J., Gasparini, L., Golding, M., Williams, M., Schiavo, G., Goedert, M., Amos, L.A. and Spillantini, M.G. (2007) Interaction of tau protein with the dynactin complex. EMBO J., 26, 4546-4554.
29. Harada, A., Oguchi, K., Okabe, S., Kuno, J., Terada, S., Ohshima, T., Sato-Yoshitake, R., Takei, Y., Noda, T. and Hirokawa, N. (1994) Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature, 369, 488-491.
30. Bu, B., Klunemann, H., Suzuki, K., Li, J., Bird, T., Jin, L.W. and Vincent, I. (2002) Niemann-Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. Neurobiol. Dis., 11, 285-297.
31. Sawamura, N., Gong, J.S., Garver, W.S., Heidenreich, R.A., Ninomiya, H., Ohno, K., Yanagisawa, K. and Michikawa, M. (2001) Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice. J. Biol. Chem., 276, 10314-10319.
32. Zhang, M., Li, J., Chakrabarty, P., Bu, B. and Vincent, I. (2004) Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice. Am. J. Pathol., 165, 843-853.
33. Klionsky, D.J. and Emr, S.D. (2000) Autophagy as a regulated pathway of cellular degradation. Science, 290, 1717-1721.
34. Martinez-Vicente, M. and Cuervo, A.M. (2007) Autophagy and neurodegeneration: When the cleaning crew goes on strike. Lancet Neurol., 6, 352-361.
35. Rubinsztein, D.C., Gestwicki, J.E., Murphy, L.O. and Klionsky, D.J. (2007) Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov., 6, 304-312.
36. Settembre, C., Fraldi, A., Jahreiss, L., Spampanato, C., Venturi, C., Medina, D., de Pablo, R., Tacchetti, C., Rubinsztein, D.C. and Ballabio, A. (2008) A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet., 17, 119-129.
37. Settembre, C., Fraldi, A., Rubinsztein, D.C. and Ballabio, A. (2008) Lysosomal storage diseases as disorders of autophagy. Autophagy, 4, 113-114.
38. Ko, D.C., Milenkovic, L., Beier, S.M., Manuel, H., Buchanan, J. and Scott, M.P. (2005) Cell-autonomous death of cerebellar purkinje neurons with autophagy in Niemann-Pick type C disease. PLoS Genet., 1 81-95.
39. Liao, G., Yao, Y., Liu, J., Yu, Z., Cheung, S., Xie, A., Liang, X. and Bi, X. (2007) Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1-/- mouse brain. Am. J. Pathol., 171, 962-975.
40. Pacheco, C.D., Kunkel, R. and Lieberman, A.P. (2007) Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects. Hum. Mol. Genet., 16, 1495-1503.
41. Iwata, A., Riley, B.E., Johnston, J.A. and Kopito, R.R. (2005) HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J. Biol. Chem., 280, 40282-40292.
42. Ravikumar, B., Acevedo-Arozena, A., Imarisio, S., Berger, Z., Vacher, C., O'Kane, C.J., Brown, S.D. and Rubinsztein, D.C. (2005) Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet., 37, 771-776.
43. Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H. et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature, 441, 885-889.
44. Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E. et al. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature, 441, 880-884.
45. Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y. and Yoshimori, T. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J., 19, 5720-5728.
46. Tanida, I., Ueno, T. and Kominami, E. (2004) Human light chain 3/ MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes. J. Biol. Chem. 279, 47704-47710.
47. Corcelle, E., Nebout, M., Bekri, S., Gauthier, N., Hofman, P., Poujeol, P., Fenichel, P. and Mograbi, B. (2006) Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity. Cancer Res., 66, 6861-6870.
48. Settembre, C., Fraldi, A., Jahreiss, L., Spampanato, C., Venturi, C., Medina, D., de Pablo, R., Tacchetti, C., Rubinsztein, D.C. and Ballabio, A. (2008) A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet., 17, 119-129.
49. Cao, Y., Espinola, J.A., Fossale, E., Massey, A.C., Cuervo, A.M., MacDonald, M.E. and Cotman, S.L. (2006) Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J. Biol. Chem., 281, 20483-20493.
50. Vergarajauregui, S., Connelly, P.S., Daniels, M.P. and Puertollano, R. (2008) Autophagic dysfunction in mucolipidosis type Iv patients. Hum. Mol. Genet., 17, 2723-2737.
51. Komatsu, M., Waguri, S., Koike, M., Sou, Y.S., Ueno, T., Hara, T., Mizushima, N., Iwata, J.I., Ezaki, J., Murata, S. et al. (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell, 131, 1149-1163.
52. Gozuacik, D. and Kimchi, A. (2007) Autophagy and cell death. Curr. Top. Dev. Biol., 78, 217-2145.
53. Ingelson, M., Vanmechelen, E. and Lannfelt, L. (1996) Microtubule-associated protein tau in human fibroblasts with the Swedish Alzheimer mutation. Neurosci. Lett., 220, 9-12.
54. Auteri, J.S., Okada, A., Bochaki, V. and Dice, J.F. (1983) Regulation of intracellular protein degradation in IMR-90 human diploid fibroblasts. J. Cell. Physiol., 115, 167-174.
55. Cuervo, A.M. and Dice, J.F. (1996) A receptor for the selective uptake and degradation of proteins by lysosomes. Science, 273, 501-503.
56. Fuertes, G., Martin De Llano, J.J., Villarroya, A., Rivett, A.J. and Knecht, E. (2003) Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions. Biochem. J., 375, 75-86.
57. Le Tallec, B., Barrault, M.B., Courbeyrette, R., Guerois, R., Marsolier-Kergoat, M.C. and Peyroche, A. (2007) 20S proteasome assembly is orchestrated by two distinct pairs of chaperones in yeast and in mammals. Mol. Cell, 27, 660-674.
58. Hasegawa, M. (2006) Biochemistry and molecular biology of tauopathies. Neuropathology, 26, 484-490.
59. Goedert, M., Crowther, R.A. and Spillantini, M.G. (1998) Tau mutations cause frontotemporal dementias. Neuron, 21, 955-958.
60. Heutink, P. (2000) Untangling tau-related dementia. Hum. Mol. Genet. 9, 979-986.
61. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A. et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393, 702-705.
62. Roberson, E.D., Scearce-Levie, K., Palop, J.J., Yan, F., Cheng, I.H., Wu, T., Gerstein, H., Yu, G.Q. and Mucke, L. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science, 316, 750-754.
63. Runz, H., Dolle, D., Schlitter, A.M. and Zschocke, J. (2008) NPC-db, a Niemann-Pick type C disease gene variation database. Hum. Mutat., 29, 345-350.
64. Fink, J.K., Filling-Katz, M.R., Sokol, J., Cogan, D.G., Pikus, A., Sonies, B., Soong, B., Pentchev, P.G., Comly, M.E., Brady, R.O. et al. (1989) Clinical spectrum of Niemann-Pick disease type C. Neurology, 39, 1040-1049.
65. Yatziv, S., Leibovitz-Ben Gershon, Z., Ornoy, A. and Bach, G. (1983) Clinical heterogeneity in a sibship with Niemann-Pick disease type C. Clin. Genet., 23, 125-131.
66. Vanier, M.T., Duthel, S., Rodriguez-Lafrasse, C., Pentchev, P. and Carstea, E.D. (1996) Genetic heterogeneity in Niemann-Pick C disease: A study using somatic cell hybridization and linkage analysis. Am. J. Hum. Genet., 58, 118-125.
67. Vanier, M.T., Rodriguez-Lafrasse, C., Rousson, R., Duthel, S., Harzer, K., Pentchev, P.G., Revol, A. and Louisot, P. (1991) Type C Niemann-Pick disease: Biochemical aspects and phenotypic heterogeneity. Dev. Neurosci., 13, 307-314.